PropertyValue
?:definition
  • Molecular assay reagents intended to identify mutations in genes associated with Stargardt disease, a form of macular dystrophy typically characterized by the accumulation of lipofuscin in cells underlying the macula, which leads to progressive central and night vision loss. Genetic variants at multiple loci have been associated with Stargardt disease. These reagents are intended to detect mutations in multiple Stargardt disease-associated loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4286676_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4286676_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all